Flexible Biomanufacturing Processes that Address the Needs of the Future

Area of Science:

• Biopharmaceutical Manufacturing
• Process Engineering
• Industrial Biotechnology

Background:

• The traditional biopharmaceutical manufacturing model, centered on large, capital-intensive facilities, is becoming obsolete due to industry shifts.
• Factors like personalized medicine, biosimilars, biobetters, and global vaccine demand necessitate new manufacturing strategies.
• Existing infrastructure struggles to meet evolving production and economic requirements.

Purpose of the Study:

• To propose a new approach for designing and implementing flexible production processes for monoclonal antibodies.
• To outline key considerations and lessons learned from past experiences in engineering biomanufacturing systems.
• To present a conceptual integrated design as a blueprint for next-generation biomanufacturing facilities.

Main Methods:

• Review of industry trends and challenges in biopharmaceutical manufacturing.
• Development of a conceptual integrated design for flexible biomanufacturing.
• Analysis of benefits including flexibility, cost-effectiveness, and schedule adherence.

Main Results:

• A new approach to designing flexible production processes for monoclonal antibodies is described.
• A conceptual integrated design serves as a blueprint for next-generation facilities.
• The proposed approach demonstrates benefits in flexibility, cost reduction, and improved project schedules.

Conclusions:

• The traditional large-scale manufacturing strategy is insufficient for the evolving biopharmaceutical industry.
• Flexible, integrated biomanufacturing designs are essential for future production needs.
• The presented concept is applicable to various biopharmaceutical manufacturing processes, including vaccines and clinical manufacturing.